医药行业分析
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-18)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-17)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
百济神州于2019年欧洲肿瘤内科学会免疫肿瘤学大会公布在研抗PD-1抗体替雷利珠单抗联合sitravatinib的临床数据
(2019-12-16)- (2019-12-16)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)